Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. American Herbal Laboratories, Inc
EIR
•American Herbal Laboratories, Inc•September 10, 2021

American Herbal Laboratories, Inc – FDA EIR, Sep 10, 2021

Record Details

American Herbal Laboratories, Inc. underwent an FDA inspection from August 25 to September 10, 2021. The surveillance inspection, conducted under 21 CFR 111 for dietary supplement Current Good Manufacturing Practices (cGMPs), identified 12 significant observations on an FDA Form 483, some of which were repeat violations from previous inspections. Key violations centered on quality control and manufacturing documentation. The company failed to conduct appropriate identity testing for dietary ingredients prior to use and lacked established specifications for limits on contamination (e.g., pathogens, pesticide residues, heavy metals) for dietary ingredients, with no finished product microbiological testing since 2018. Further, the firm did not establish comprehensive finished product specifications for identity and composition, nor identity specifications for each component. Deficiencies in Master Manufacturing Records (MMRs) were noted, including the absence of batch sizes, accurate component weights/measures, theoretical yields, and clear instructions requiring dual verification. Written instructions also lacked in-process specifications and detailed manufacturing steps. Additionally, the firm failed to collect retention samples of dietary ingredients. Beyond the 483 observations, the inspection highlighted labeling concerns, such as the absence of supplement facts on outer packaging and potential medical claims on the company's website. Quality control personnel were also found not to be properly approving batch records. President Luke Cua committed to providing written corrections for the observations and a response regarding the labeling issues within 15 business days.

Company
American Herbal Laboratories, Inc
Inspection date
September 10, 2021
Product type
Dietary Supplements
Office
Los Angeles District Office
Person
  • Phal K. Chhun (investigator)
View Company Profile

ID · 798f7376-69dc-4824-846d-3b019f8b3a44

Violation Codes10
21 CFR 111.70(e)21 CFR 11121 CFR 111.210(h)(3)21 CFR 111.205(a)21 CFR 111.70(b)(3)21 CFR 111.105(f)21 CFR 21121 CFR 111.210(h)(1)21 CFR 111.210(f)21 CFR 111.210(h)(3)(ii)(B)

Full citation text and observation details available on the Dashboard.

Other documents for American Herbal Laboratories, Inc
  • 483 - 2021-09-10September 10, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore American Herbal Laboratories, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.